Morgan Stanley analyst Robert Davies raised the firm’s price target on Fresenius Medical to EUR 40.50 from EUR 37.80 and keeps an Equal Weight rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on FMS:
- Fresenius Medical downgraded to Neutral from Buy at UBS
- Fresenius Medical price target raised to EUR 46 from EUR 38 at Deutsche Bank
- Fresenius Medical price target raised to EUR 45 from EUR 42 at Credit Suisse
- Fresenius Medical price target raised to EUR 38 from EUR 36 at Barclays
- Fresenius Medical price target raised to EUR 54 from EUR 50.90 at Berenberg